Asaio J
-
Publication Venue For
- Palliative Care Engagement for Pediatric Ventricular Assist Device Patients: A Single-Center Experience.. 66:929-932. 2020
- Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. 2020
- A Minimally Invasive Approach to HeartMate 3 Implantation for Systemic Ventricular Failure Following the Mustard Procedure for Transposition of the Great Arteries.. 66:e62-e63. 2020
- Acute Kidney Injury, Fluid Overload, and Outcomes in Children Supported With Extracorporeal Membrane Oxygenation for a Respiratory Indication.. 66:319-326. 2020
- Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.. 66:307-313. 2020
- The HeartMate 6.. 66:e46-e49. 2020
- LVAD Outflow Graft Role in Pump Thrombosis.. 66:128-131. 2020
- Prothrombin Complex Concentrate Use in Durable and Short-Term Left Ventricular Assist Device Implantation.. 66:e8-e10. 2020
- Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis.. 65:436-441. 2019
- Pulmonary Hypertension in the Era of Mechanical Circulatory Support.. 62:505-512. 2016
- Achieving 12 Hour Normothermic Ex Situ Heart Perfusion: An Experience of 40 Porcine Hearts.. 62:470-476. 2016
- Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.. 62:232-239. 2016
- Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.. 62:291-296. 2016
- Early Experience with a Novel Cannulation Strategy for Left Ventricular Decompression during Nonpostcardiotomy Venoarterial ECMO.. 62:e30-e34. 2016
- Large Animal Model of Pumpless Arteriovenous Extracorporeal CO₂ Removal Using Room Air via Subclavian Vessels.. 62:110-113. 2016
- Successful Porcine Renal Transplantation After 60 Minutes of Donor Warm Ischemia: Extracorporeal Perfusion and Thrombolytics.. 61:474-479. 2015
- The Implantable Pediatric Artificial Lung: Interim Report on the Development of an End-Stage Lung Failure Model.. 61:453-458. 2015
- Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis.. 61:190-195. 2015
- Outcomes after implantable left ventricular assist device replacement procedures.. 60:44-48. 2014
- A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease.. 59:668-670. 2013
- Dysphagia in the setting of left ventricular assist device hemolysis.. 59:322-323. 2013
- Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.. 59:63-68. 2013
- Allosensitization in cardiac transplantation: shooting at a moving target.. 58:548-549. 2012
- Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.. 56:441-445. 2010
- An Artificial Placenta Protects Against Lung Injury and Promotes Continued Lung Development in Extremely Premature Lambs.. 65:690-697.
- Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support.. 64:16-23.
- Associations of Preimplant Red Blood Cell Distribution Width with Clinical Outcomes Among Individuals with Left Ventricular Assist Devices.. 62:677-683.
- Cerebral Oxygenation of Premature Lambs Supported by an Artificial Placenta.. 64:552-556.
- ECMO: 40 Years Later.. 63:693-694.
- Efficacy of Flow Monitoring During ECMO.. 63:496-500.
- Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis.. 64:424-426.
- Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure.. 65:389-394.
- Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device.. 63:e47-e49.
- Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry.. 64:218-224.
- Intravenous Versus Oral Iron Replacement in Patients with a Continuous-Flow Left Ventricular Assist Device.. 65:e90-e91.
- Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.. 63:251-256.
- Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction.. 64:e40-e42.
- Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device.. 62:646-651.
- Pediatric Artificial Lung: A Low-Resistance Pumpless Artificial Lung Alleviates an Acute Lamb Model of Increased Right Ventricle Afterload.. 63:223-228.
- Physiological and Psychological Stress in Patients Living With a Left Ventricular Assist Device.. 64:e172-e180.
- Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support.. 63:536-541.
- Re: Desmopressin Use in Refractory Gastrointestinal Bleeding in LVAD Patient.. 63:e70.
- Vascular Complications and Use of a Distal Perfusion Cannula in Femorally Cannulated Patients on Extracorporeal Membrane Oxygenation.. 64:328-333.
- Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device.. 63:731-735.
- iPhone in the Management of the Berlin Heart EXCOR Ventricular Assist Device.. 64:278-279.